BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29110679)

  • 1. High-throughput gadobutrol-enhanced CMR: a time and dose optimization study.
    D'Angelo T; Grigoratos C; Mazziotti S; Bratis K; Pathan F; Blandino A; Elen E; Puntmann VO; Nagel E
    J Cardiovasc Magn Reson; 2017 Nov; 19(1):83. PubMed ID: 29110679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
    Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of extracellular contrast agent (Gadobutrol) on the precision and reproducibility of cardiovascular magnetic resonance feature tracking.
    Kuetting DL; Dabir D; Homsi R; Sprinkart AM; Luetkens J; Schild HH; Thomas DK
    J Cardiovasc Magn Reson; 2016 May; 18(1):30. PubMed ID: 27209219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motion-corrected free-breathing LGE delivers high quality imaging and reduces scan time by half: an independent validation study.
    Captur G; Lobascio I; Ye Y; Culotta V; Boubertakh R; Xue H; Kellman P; Moon JC
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1893-1901. PubMed ID: 31104178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive evaluation of macroscopic and microscopic myocardial fibrosis by cardiac MR: intra-individual comparison of gadobutrol versus gadoterate meglumine.
    Rahsepar AA; Ghasemiesfe A; Suwa K; Dolan RS; Shehata ML; Korell MJ; Naresh NK; Markl M; Collins JD; Carr JC
    Eur Radiol; 2019 Aug; 29(8):4357-4367. PubMed ID: 30617490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image quality of late gadolinium enhancement in cardiac magnetic resonance with different doses of contrast material in patients with chronic myocardial infarction.
    Monti CB; Codari M; Cozzi A; Alì M; Saggiante L; Sardanelli F; Secchi F
    Eur Radiol Exp; 2020 Apr; 4(1):21. PubMed ID: 32242266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compressed sensing real-time cine cardiovascular magnetic resonance: accurate assessment of left ventricular function in a single-breath-hold.
    Kido T; Kido T; Nakamura M; Watanabe K; Schmidt M; Forman C; Mochizuki T
    J Cardiovasc Magn Reson; 2016 Aug; 18(1):50. PubMed ID: 27553656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study.
    Chubb H; Aziz S; Karim R; Sohns C; Razeghi O; Williams SE; Whitaker J; Harrison J; Chiribiri A; Schaeffter T; Wright M; O'Neill M; Razavi R
    J Cardiovasc Magn Reson; 2018 May; 20(1):30. PubMed ID: 29720202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical combined gadobutrol bolus and slow infusion protocol enabling angiography, inversion recovery whole heart, and late gadolinium enhancement imaging in a single study.
    Tandon A; James L; Henningsson M; Botnar RM; Potersnak A; Greil GF; Hussain T
    J Cardiovasc Magn Reson; 2016 Oct; 18(1):66. PubMed ID: 27716273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction.
    Pi SH; Kim SM; Choi JO; Kim EK; Chang SA; Choe YH; Lee SC; Jeon ES
    J Cardiovasc Magn Reson; 2018 Jun; 20(1):36. PubMed ID: 29898740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Image-navigated 3-dimensional late gadolinium enhancement cardiovascular magnetic resonance imaging: feasibility and initial clinical results'.
    Bratis K; Henningsson M; Grigoratos C; Dell'Omodarme M; Chasapides K; Botnar R; Nagel E
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):97. PubMed ID: 29202776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Validation of a 3-Dimensional Ultrafast Cardiac Magnetic Resonance Protocol Including Single Breath-Hold 3-Dimensional Sequences.
    Gómez-Talavera S; Fernandez-Jimenez R; Fuster V; Nothnagel ND; Kouwenhoven M; Clemence M; García-Lunar I; Gómez-Rubín MC; Navarro F; Pérez-Asenjo B; Fernández-Friera L; Calero MJ; Orejas M; Cabrera JA; Desco M; Pizarro G; Ibáñez B; Sánchez-González J
    JACC Cardiovasc Imaging; 2021 Sep; 14(9):1742-1754. PubMed ID: 33865783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D whole-heart phase sensitive inversion recovery CMR for simultaneous black-blood late gadolinium enhancement and bright-blood coronary CMR angiography.
    Ginami G; Neji R; Rashid I; Chiribiri A; Ismail TF; Botnar RM; Prieto C
    J Cardiovasc Magn Reson; 2017 Nov; 19(1):94. PubMed ID: 29178893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy - a prospective clinical cardiovascular magnetic resonance trial.
    Muehlberg F; Arnhold K; Fritschi S; Funk S; Prothmann M; Kermer J; Zange L; von Knobelsdorff-Brenkenhoff F; Schulz-Menger J
    J Cardiovasc Magn Reson; 2018 Feb; 20(1):13. PubMed ID: 29458430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
    Gulsin GS; Shetye A; Khoo J; Swarbrick DJ; Levelt E; Lai FY; Squire IB; Arnold JR; McCann GP
    BMC Cardiovasc Disord; 2017 Apr; 17(1):98. PubMed ID: 28390413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of contrast enhanced cine steady-state free precession and T2-weighted CMR for assessment of ischemic myocardial area-at-risk in the presence of reperfusion injury.
    Hansen ESS; Pedersen SF; Pedersen SB; Bøtker HE; Kim WY
    Int J Cardiovasc Imaging; 2019 Jun; 35(6):1039-1045. PubMed ID: 30852704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach.
    Boentert M; Florian A; Dräger B; Young P; Yilmaz A
    J Cardiovasc Magn Reson; 2016 Dec; 18(1):91. PubMed ID: 27931223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis.
    Ammirati E; Moroni F; Sormani P; Peritore A; Milazzo A; Quattrocchi G; Cipriani M; Oliva F; Giannattasio C; Frigerio M; Roghi A; Camici PG; Pedrotti P
    Int J Cardiol; 2017 Mar; 231():216-221. PubMed ID: 27913009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
    Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.